Supervised Exercise Improves Patient-Reported Outcomes for Metastatic Breast Cancer
By Lori Solomon HealthDay Reporter
WEDNESDAY, March 27, 2024 -- Supervised exercise during palliative treatment leads to beneficial effects on fatigue and health-related quality of life (HRQoL) among patients with metastatic breast cancer, according to a study presented at the annual European Breast Cancer Conference, held from March 20 to 22 in Milan.
Anouk Hiensch, from University Medical Center Utrecht in the Netherlands, and colleagues assessed the effects of a nine-month supervised exercise program on fatigue, HRQoL, and cancer- and treatment-related adverse effects among subsets of 357 patients with metastatic breast cancer.
The researchers found that at six months, participation in the exercise program resulted in statistically significant positive effects on both primary outcomes versus usual care (physical fatigue: effect size, 0.22; HRQoL: effect size, 0.33). There were also positive effects on pain subscales (effect size, 0.28). There were no significant differences seen in these positive effects as a function of tumor receptor status or disease-free interval. Larger HRQoL effects were observed among patients who were younger (<50 years: +8.4 versus ≥50 years: +3.3) and those who reported pain above the clinically important threshold at baseline versus those without pain.
"Based on these findings, we recommend supervised exercise for all patients, and in particular those who report pain, as part of supportive care regimens during palliative treatment of metastatic breast cancer," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Psoriasis, With or Without Psoriatic Arthritis, Associated With Fatigue
MONDAY, July 1, 2024 -- Psoriasis is associated with fatigue, especially among those with psoriatic arthritis (PsA), according to a study published in the July issue of the...
NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians
FRIDAY, June 28, 2024 -- Almost 90 percent of medical centers report cancer drug shortages, which often impact clinical trials, according to the results of a National...
RA Patients With Mono-, Oligo-Arthritis, High PGA Remain Most Fatigued
FRIDAY, June 28, 2024 -- Rheumatoid arthritis (RA) patients with mono- or oligo-arthritis and high Patient Global Assessment (PGA) at diagnosis remain the most fatigued, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.